NCT06478927View on ClinicalTrials.gov

Backline Treatment of Advanced Hepatocellular Carcinoma With Palbociclib

NARecruitingINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

January 15, 2026

Study Completion Date

January 15, 2027

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

Palbociclib capsules

Palbociclib capsules, oral, 125 mg/dose, qd, take 3 weeks and then stop for 1 week, 28d for one treatment cycle until disease progression or intolerable toxicity.

Trial Locations (1)

Unknown

RECRUITING

Henan Cancer Hospital, Zhengzhou

All Listed Sponsors
lead

Henan Cancer Hospital

OTHER_GOV